Introduction
found that placing 3T3 cells in suspension had either a modest effect (Zhu and Assoian, 1995) or no effect The MAP kinase pathway is a major cellular signaling (Hotchin and Hall, 1995) on activation of ERKs by growth pathway that mediates effects of growth factors on cell factors. These results are paradoxical, since growth factors cycle progression (reviewed in Crews and Erikson, 1993;  do not induce DNA synthesis in suspended cells, yet Cobb et al., 1994; Marshall, 1995) . Growth factors induce activated variants of Ras, Raf or MEK1 do. conversion of c-Ras to its GTP-bound form, which then
To resolve this paradox, we investigated in greater binds the protein kinase c-Raf. Localization of Raf to the detail the involvement of cell adhesion in growth factor plasma membrane leads to its activation via mechanisms activation of the MAP kinase pathway. We found that that are incompletely understood but that appear to involve activation of ERK2 was in fact strongly dependent on its phosphorylation (Morrison et al., 1988; Jelinek et al., adhesion to extracellular matrix. Furthermore, we identi-1996) . Once activated, Raf phosphorylates and activates fied activation of MEK by Raf as the adhesion-dependent the protein kinase MEK1, which phosphorylates and step. Thus, constitutive activation of the MAP kinase activates the MAP kinases ERK1 and ERK2. These kinases pathway by oncogenes can bypass the requirement for phosphorylate a number of substrates that participate in both growth factors and cell adhesion. cell cycle regulation, including the transcription factor Elk-1 (Janknecht et al., 1993) , phospholipase A 2 (Lin et al., 1993) and p90 RSK (Sturgill et al., 1988; Chung Results et al., 1991) .
This pathway also plays a key role in oncogenic
Inhibition of ERK2 activity in suspended cells
To test the possible dependence of the MAP kinase ERK2 transformation, as activated forms of Ras are among the most common mutations found in human tumors (Cobb on adhesion, cells were detached and either held in suspension in medium with 0.4% serum for 24 h or et al., Marshall, 1995) and expression of activated Cells that had been incubated for 24 h in 0.4% serum while attached or suspended were stimulated by addition of 10% serum for the indicated times. Endogenous ERK was immunoprecipitated and analyzed for kinase activity using the in-gel assay and for ERK2 protein by Western blotting. Quantitation of the kinase assay is shown graphically. Data are representative of eight experiments. (B) Stimulation by PDGF. Attached or suspended cells that were incubated in 0.4% serum were stimulated by addition of 20 ng/ml PDGF for the indicated times. Endogenous ERK2 activity and amounts of immunoprecipitated protein were assayed as in (A). Quantitation of the kinase assay by densitometry is shown graphically. Data are representative of three experiments. (C) Stimulation by LPA. Attached or suspended cells were incubated in 0.4% serum, then stimulated with 2 μg/ml LPA for the indicated times. Endogenous ERK2 was immunoprecipitated and its activity determined in the immunoprecipitates. Kinase activity is shown graphically. Data are representative of four experiments. (D) Stimulation by TPA. Adherent cells kept in low serum for 24 h, serum-starved cells that were trypsinized and kept in suspension for 3 h, or cells kept in suspension in low serum for 24 h were stimulated with 100 nM TPA for 10 min. ERK2 kinase activity and immunoprecipitated protein amounts were assayed as before. The lower panel shows the quantitation of ERK2 kinase activity normalized for protein levels; values are means Ϯ standard deviations from three experiments.
replated on tissue culture plastic in low serum for the sion for short periods of time still activate MAP kinase in response to growth factors (Hotchin and Hall, 1995; same period. Subsequent stimulation with 10% serum induced strong activation of ERK2 in adherent cells but Zhu and Assoian, 1995) . To resolve the conflict between our results and these reports, we analyzed the effect of only a slight increase in suspended cells ( Figure 1A) . In eight experiments, inhibition varied between 97% and leaving cells in suspension for various lengths of time.
We found that cells which were detached and held in 77%, averaging 90.2 Ϯ 9.8%. Platelet-derived growth factor (PDGF) and lysophosphatidic acid (LPA) are two suspension for short periods of time retained the ability to activate ERK2 in response to serum (Figure 2 ). With of the major mitogens in serum. We therefore examined the stimulation of ERK2 activity by purified PDGF and longer times in suspension, ERK2 activation diminished, with a half-time of~6 h. These results indicate that loss LPA. Both mitogens strongly activated ERK2 in adherent cells but showed a substantially reduced response in nonof structures such as focal adhesions or dephosphorylation of focal adhesion proteins such as focal adhesion kinase, adherent cells (Figure 1B and C) Previous studies have shown that cells placed in suspenpaxillin, p130 cas or tensin, which occur rapidly upon loss has shown that the PDGF receptor is still functional Alternatively, as shown in the lower panel, cells were replated on even after prolonged incubation of cells in suspension plastic with different coating. These were: 20 μg/ml FN; 100 μg/ml polylysine (PL); 20 μg/ml anti-mouse β 1 integrin IgG (β1); 25 μg/ml (McNamee et al., 1992) . To test this idea further, we goat anti-mouse IgG followed by 20 μg/ml anti-mouse β 1 IgG (2nd examined the activation of ERK2 by the phorbol ester β1). In these experiments, the plastic was subsequently blocked with TPA, which activates Raf via protein kinase C, bypassing 10 mg/ml heat-denatured BSA to prevent adhesion via secreted FN.
Ras and the membrane receptors. The ability of TPA to Figure 1D ).
shown).
Reversibility
To examine whether MAP kinase activation could be stimulus (adhesion). Thus, the failure to respond to serum is specific to soluble growth factors and cannot be due to restored by replating cells on the extracellular matrix protein FN, two experiments were performed. First, cells general toxicity or apoptosis.
To test whether replating restores the ability to respond that were kept in suspension for either 3 or 24 h were replated on FN. The cells that had been in suspension for to serum, 24 h suspended cells were replated on FN in low serum for various times and then stimulated with 24 h adhered and spread at a significantly slower rate, though in both cases cells were well spread by 60 min serum. ERK2 activity was then assayed. We observed that upon replating, cells regained the ability to activate ERK2 (data not shown). Assay of ERK2 activity in these cells showed that the activation of ERK2 in cells kept in in response to serum ( Figure 3B ). The activation by replating alone in the absence of serum was, as in Figure  suspension for 24 h was delayed relative to cells kept in suspension for 3 h ( Figure 3A ). Presumably this delay is 3A, readily detectable at 1 h, followed by a return to baseline by 2 h. However, the increase in activity due to due to the delay in attachment and spreading. However, the extent of ERK2 activation was equivalent in the cells serum was readily detected at the 1 h time point. Interestingly, the serum response was diminished at the 2 h time suspended for 24 h. This result shows that ERK2 can still be activated in 24 h suspended cells by an appropriate point. This effect is most likely due to the fact that Next, we assayed Raf function by immunoprecipitating cellular Raf and carrying out an in vitro kinase assay using stimulation of MAP kinases by replating alone may render cells refractory to subsequent stimulation by serum, due kinase-defective MEK1 as a substrate. These experiments showed that Raf kinase was still activated in suspended to induction of the ERK phosphatase MKP-1 (Sun et al., 1993) . Recovery of MAP kinase activation was also cells, with only a slight (~10%) decrease relative to adherent cells ( Figure 5 ). Thus, activation of Raf is not observed when cells were replated on an antibody to the integrin β1 subunit, but not on polylysine. Treatment of significantly adhesion-dependent. We then immunoprecipitated cellular MEK1, and cells with cycloheximide did not block the recovery of MAP kinase activation (data not shown), but did reduce examined its kinase activity using kinase-defective ERK2 as a substrate. These experiments revealed that activation cell spreading and slightly reduced MAP kinase activation. These results show that the inhibition of ERK2 in susof endogenous MEK1 in response to serum was greatly reduced in non-adherent cells (Figure 6 ), to an extent that pended cells is reversible and is integrin-dependent.
was similar to the inhibition of ERK2. Thus, the ability of Raf to activate MEK1 appears to be the step that is
Activation of intermediates
It is well established that growth factors activate ERK2 sensitive to adhesion. via a pathway that involves Ras, Raf and MEK1. To determine which step(s) in the pathway require cell adhe-
Activated components
To confirm the results of experiments analyzing the sion, we assayed the activation of these components in adherent and suspended cells. Ras activation was assayed activities of cellular Ras, Raf and MEK1, we carried out a second series of experiments to study the activation of by immunoprecipitating endogenous Ras protein and analyzing the bound nucleotide. We observed that the baseline ERK2 by constitutively activated mutants. Cells were transiently transfected with ras G12V, which is constitu-GTP content was somewhat lower in suspended cells; however, treatment with serum stimulated GTP loading tively activated by a mutation that reduces its GTPase; with raf BxB, in which the kinase is constitutively activated to the same level in adherent and suspended cells (Figure 4) . Thus, the adhesion-dependent step must lie by truncation of the regulatory domain; or by ΔN3, S222 MEK1, which is activated by a deletion and a point downstream of Ras. transfected with an ERK2 that had been tagged with the hemagglutinin (HA) epitope. Control cells were cotransfected with HA-ERK2 plus empty vector. At 24 h with MEK alone induced foci rather weakly, as reported previously (Khosravi-Far et al., 1995; White et al., 1995) . after transfection, cells were placed in suspension or replated on tissue culture plastic in low serum, and
This result is consistent with the concept that ras induces transformation via combined effects on a number of incubated a further 24 h. The HA-ERK2 was then immunoprecipitated and its activity assayed. These results show effectors. Co-transfection of MEK with ras did not increase the number of foci or colonies, but this may be due to that ERK2 activation by both Ras and Raf were decreased in suspended cells to~15% of the levels in adherent cells the already high efficiency of transformation by ras alone. However, MEK substantially increased the size of the (Figure 7) . By contrast, activation of ERK2 by activated MEK1 remained high in non-adherent cells. These results colonies in soft agar (Table II) . Measurement of their volume showed that MEK1 enhanced the rate of growth confirm that the adhesion-dependent step lies between Raf and MEK. It should be noted, however, that the activation of cells in suspension by~7-fold. By contrast, MEK1 did not increase the size of adherent ras-transformed colonies of ERK2 by these oncogenes in adherent cells is~2.5-fold higher than that triggered by serum in adherent in low serum. These results show that preventing the decline in MAP kinase in non-adherent cells significantly cells (not shown). Hence, the activation by oncogenes in suspended cells, while strongly attenuated, is~40% of augments their growth in suspension but does not enhance the ability of ras to promote serum-independent growth that found in adherent cells treated with serum.
in adherent cells.
Cell growth
The results obtained above make a surprising prediction.
Discussion
Present views of the MAP kinase pathway would argue against the idea that activated MEK1 should augment Our results show that in NIH 3T3 cells, activation of the MAP kinase pathway by serum or growth factors is transformation by Ras. However, our data suggest that expression of MEK1 should enhance MAP kinase activity strongly dependent on integrin-mediated cell adhesion to extracellular matrix protein. Similar results were obtained and growth in suspended cells. To test this hypothesis, cells were transfected with activated ras alone, activated with CHO cells (P.E.Hughes and M.H.Ginsberg, personal communication), but other cell types have yet to be MEK1 alone, or both. Growth of transfected cells in monolayer and in suspension was then examined.
examined. Several results demonstrate that this effect is due to a specific blockade rather than to general toxicity: As shown in Table I , ras induced a significant number of foci in monolayer culture and a similar number of suspended cells retain the ability to activate MAP kinase in response to adhesion, they retain the ability to activate colonies in soft agar. The number of foci and colonies was nearly equal to the total number of hygromycinRas and Raf in response to growth factors, and the effect is reversed when cells are replated on FN. resistant colonies, suggesting that ras induced transformation of NIH 3T3 cells with high efficiency. Transfection
Two independent lines of experimentation show that et al., 1994) , or as yet unidentified protein kinases or such as mutated forms of Ras, Raf and MEK1, induce phosphatases that may regulate MEK1 activity. Further growth of cells in suspension. If MAP kinase were fully work will be required to resolve these issues. activated by growth factors in normal, suspended cells,
The majority of key cellular decisions about growth, then the activation of MAP kinase by oncoproteins would differentiation and survival are made on the basis of input be redundant. Our results resolve these questions and from both soluble mediators (growth factors, cytokines, suggest a model relating MAP kinase to anchoragehormones) and from extracellular matrix receptors. Thus, dependence and -independence of growth. Normal cells understanding how cellular pathways are controlled by are anchorage-dependent in part because growth factor both soluble factors and cell adhesion to extracellular activation of MAP kinase depends on cell adhesion. matrix is a major goal. Our results identify a novel Conversely, cells transformed by ras and other oncogenes synergism between cell adhesion and growth factors in that work through the MAP kinase pathway are anchoragethe activation of the MAP kinase pathway. These results independent because activation of MAP kinase bypasses are likely to be important in a variety of systems where a requirement for both adhesion and growth factors.
gene expressions, cell growth and cell survival depend This model, however, raises the question why activated upon cell adhesion. Ras or Raf are able to induce growth in suspension at all. It must be noted that the reduction of the ERK2 signal in non-adherent cells is not complete (Figure 7) . Indeed, the
Materials and methods activation of the MAP kinase pathway by these oncogenes
Reagents is so strong that the levels of ERK activity in suspended Anti-ERK2 polyclonal antibody (C-14) was purchased from Santa Cruz cells are still significant,~40% of the level in adherent, Biotechnology (Santa Cruz, CA). LipofectAMINE, Dulbecco's modified serum-treated control cells. Thus, very strong activation Eagle's medium (DMEM), serum and other reagents for cell culture of the pathway can at least partially overcome the requirewere from Gibco-BRL (Gaithersburg, MD). Anti-mouse β1 integrin IgG (HMβ1-1) was purchased from Pharmingen (San Diego, CA). Fibronectin ment for adhesion.
was prepared from human plasma as described (Miekka et al., 1982) .
The mechanism by which cell adhesion potentiates the Myelin basic protein was prepared from bovine spinal cord as described activation of MEK by Raf is currently unknown. The (Deibler et al., 1972) . Platelet-derived growth factor (PDGF), lysophosexistence of focal adhesions or the phosphorylation of phatidic acid (LPA), agarose, methylcellulose and other reagents were focal adhesion proteins are not likely to be the immediate purchased from Sigma Chemicals (St. Louis, MO) unless otherwise noted.
cause, since they are rapidly lost upon detachment whereas and MEK, analogous to the Ste5 protein in yeast (Choi DMEM with 0.4% serum and 0.5% methylcellulose were plated in scanning densitometry using the deskscan software with a Scanjett IIP scanner (Hewlett Packard). 10 cm dishes coated with 1 ml of 1% agarose which was equilibrated with DMEM. Methyl cellulose reduces cell-cell aggregation but does not otherwise affect growth or MAP kinase activity (data not shown).
Measurement of MEK 1 activity Cells were incubated as described in the text, stimulated with 10% serum Endogenous MEK 1 was immunoprecipitated from 100 μg of cell lysate or other factors, harvested and analyzed as described below. using 1 μg of anti MEK 1 (Santa Cruz Biotechnology). Immunoprecipitates were washed three times in lysis buffer, and then once in kinase Plasmids and transfection buffer (Chen et al., 1996) 10 mM Tris, pH 7.5, 10 mM MgCl 2 , 1 mM For transfections, cells were plated at a density of 4ϫ10 5 cells per 6 cm DTT. IPs were then split, using one-fifth to measure the amount of MEK dish 24 h before transfection. Cells were transfected with LipofectAMINE 1 protein and four-fifths to measure kinase activity. MEK kinase activity as described (Renshaw et al., 1996) using 0.2 μg of pCMV5 ERK2, was measured in kinase buffer containing 25 μM ATP, 5 μCi [γ-32 P]ATP 0.2 μg of pCMV5 βgal, and 1.6 mg of either pDCR ras G12V (White and 2 μg of kinase-dead GST-ERK2 (Hipskind et al., 1994) for 30 min et al., 1995) , pZIP Neo raf BXB (Bruder et al., 1992) or pMCL MEK at room temperature. Samples were electrophoresed on 10% SDS-ΔN3, S222D (Mansour et al., 1994) per plate. At 24 h after transfection, polyacrylamide gels, which were then dried and exposed to film. cells were transferred to medium containing 0.5% serum for an additional Autoradiographs were quantitated using a model I.S. 1000 digital imaging 24 h for adherent cells and for cells suspended for only 3 h. After 24 h system from Alpha-Innotech Corp. in 0.5% CS, cells from indicated plates were then trypsinized and suspended for 3 h in serum-free DMEM containing 0.1% BSA Ras-GTP loading (Calbiochem, nuclease-, protease-free), and 0.25 mg/ml soybean trypsin NIH 3T3 cells were maintained adherent in 0.4% serum or in suspension inhibitor (Sigma) over dishes which had been coated with 1% heatas before for 12 h. Cells were then transferred to phosphate-free DMEM denatured BSA (Sigma fraction V). Alternatively, for cells kept in containing 0.4% serum and 50 μCi/ml 32 P-labeled orthophosphate for suspension for 24 h, cells were trypsinized 24 h after transfection and an additional 12 h. Cells were then rinsed with cold Tris-buffered saline placed in suspension in DMEM media containing 0.5% methyl cellulose or phosphate-free DMEM and stimulated with 10% serum for 6-and 0.4% calf serum in dishes coated with 1% agarose as above.
10 min at room temperature. (Preliminary experiments demonstrated that maximal GTP loading of Ras occurred at this time interval.) Cells Cell growth and transformation assays were then rinsed three times with cold PBS, and lysed in 380 μl of For stable transformation assays, cells were transfected with RSVHyg 50 mM HEPES, pH 7.4, containing 1% NP40, 0.1% BSA, 100 mM and 1.6 μg of either the empty control vector, pDCR Ras G12V, pMCL NaCl, 15 mM MgCl 2 , 0.1 mM GTP, 0.1 mM GDP, 1 mM ATP, 10 μg/ml MEK ΔN3, S222D, or combinations thereof. After 24 h, the cells were aprotinin and leupeptin, 1 mM PMSF, and 2 μg of either a rat monoclonal changed to fresh media and allowed to grow for two more days. Cells anti-Ras antibody (Santa Cruz Biotechnology) or non-immune rat IgG were then trypsinized and a portion (1/20 th ) replated to measure focus as a control. Lysates were centrifuged at 13 000 r.p.m. for 12 min, the formation in normal media (with 10% serum), minimal media, or in soft supernatants transferred to fresh tubes and adjusted to 0.5M NaCl, 0.5% agar (with 10% serum) as previously described (Renshaw et al., 1995) . deoxycholate, 0.05% SDS. They were incubated on ice for 30 min, then Cells were also replated in media containing 200 μg/ml Hygromycin 10 μl protein G PLUS-Agarose (Santa Cruz Biotechnology) added and (Boehringer-Mannheim) to determine the total number of stably transthe samples rotated for 1 h at 4°C for 60 min. The beads were washed fected clones. Colonies were scored visually 2 weeks after transfections.
eight times, and the bound nucleotides extracted and chromatographed Soft agar colony volume was determined by visually measuring colony on polyethyleneimine paper as described (Downward et al., 1990) . diameter against a scale, from which colony volume was calculated.
Chromatograms were analyzed by autoradiography on Kodak BioMax Size of foci in low serum ('minimal medium') was determined by MS film and quantitated by densitometry. trypsinizing the foci and replating them in soft agar. The number of soft agar colonies was then counted after 2 weeks to determine the number Raf kinase assay of transformed cells per original minimal medium focus.
Adherent or suspended cells were stimulated with serum for 8 min, rinsed with cold PBS and lysed in buffer containing 50 mM HEPES, Measurement of ERK2 activity pH 7.4, 1% NP40, 100 mM NaCl, 2 mM EDTA, 10 μg/ml aprotinin Cells were stimulated as described in the Results section, rinsed with and leupeptin, 1 mM PMSF, 5 mM sodium vanadate, 20 mM NaF, cold phosphate-buffered saline (PBS) and extracted in ice-cold buffer 10 mM sodium pyrophosphate and 3 mM β-glycerophosphate. Cell containing 0.5% NP-40, 20 mM Tris, pH 7.6, 250 mM NaCl, 5 mM lysates were centrifuged at 13 000 r.p.m. in a microfuge for 15 min, and EDTA, 3 mM EGTA, 20 mM sodium phosphate, 20 mM sodium precleared with 10 μl of protein A-agarose beads (Pierce). Protein in pyrophosphate, 3 mM β-glycerophosphate, 1 mM sodium orthovanadate, each sample was assayed using the Pierce BCA Kit. Normalized samples 1 mM PMSF, 10 mM NaF, and 10 μg/ml each of leupeptin and aprotinin.
were adjusted to 0.5 M NaCl, 0.1% SDS and 0.5% deoxycholate, and Lysates were centrifuged 15 min at maximum speed in a microfuge and immunoprecipitated for 2 h at 4°C using 3 μg of mouse monoclonal the supernatants removed. For assays of transfected HA-ERK2 activity, anti-Raf1 IgG (Transduction Laboratories) and 10 μl of protein A-0.5 μg of anti-HA (12CA5) antibody purified over an HA affinity column agarose beads prebound with 10 μg of rabbit anti-mouse IgG (Cappel). was used for each immunoprecipitation. For endogenous ERK2, 0.5 μg The beads were rinsed three times with lysis buffer containing 0.5 M of anti-ERK2 was used for each immunoprecipitation. Approximately NaCl and once with lysis buffer. The in vitro Raf kinase assay was 100 μg of cell protein was immunoprecipitated in each sample. For carried out exactly as described (Morrison, 1995) using His-tagged transfected cells, the amount of cell lysate used in the IP was normalized kinase-defective MEK1 as a substrate (Gardner et al., 1994) . A portion to βgal activity levels to account for transfection efficiencies. βgal of each sample was analyzed by Western blotting with the monoclonal activity levels were measured as previously described (Herbomel et al., anti-Raf1 antibody to determine the amount of Raf in the immuno-1984) using 20 μg of the cell lysate. For assays of endogenous ERK2
precipitates. activity, samples were normalized to protein using the BCA kit from Pierce Chemicals (Rockford IL). For all immunoprecipitation, one-fifth of the samples were saved and run on a 10% SDS-polyacrylamide gels, transferred to Hybond C (Amersham), and immunoblotted using the
